AI Care in Action: Dr. Xiaoji Builds a Breast Health Shield in Hong Kong

HONG KONG – The field of breast health and cancer prevention in Hong Kong has welcomed a landmark collaboration. The “Dr. Xiaoji AI-Powered Ultrasound Breast Cancer Screening Robot” has announced a partnership with the Hong Kong Cancer Fund Angel Service Society and Hong Kong Health Research Point to officially introduce its advanced AI ultrasound screening technology to communities across the city. This initiative aims to empower women’s health through technology, making accurate screening accessible and building a formidable, AI-powered line of defense for the health of all age-appropriate women in Hong Kong.

Globally, an estimated 40% of women have dense breasts. For this group, traditional mammograms (X-rays) carry a higher risk of missed diagnoses, as lesions can be masked by dense glandular tissue. Ultrasound is the most flexible and effective standard of care for the early screening of breast cancer in women with dense breasts. However, traditional ultrasound screening has long faced industry-wide challenges, including a severe shortage of qualified sonographers, a high dependency on operator experience, and a lack of standardization in diagnostics.

Technology is breaking this bottleneck. The Dr. Xiaoji AI-Powered Ultrasound Breast Cancer Screening Robot, driven by its proprietary AI algorithms, is pioneering an operator-independent era in early breast cancer screening. Staff with minimal training can operate the device to perform rapid, accurate, non-invasive, and standardized data acquisition and analysis. This not only addresses the critical shortage of ultrasound specialists in medical institutions but also leverages the exceptional consistency of AI to significantly reduce the rates of missed and misdiagnosed cases, making accurate early screening truly accessible to the public.

(The Dr. Xiaoji AI Ultrasound Screening Robot at work in a Hong Kong community, enabling efficient and accurate operator-independent screening.)

The choice of partners for this Hong Kong launch was highly strategic.

The Hong Kong Cancer Fund Angel Service Society, founded in 1987, is a benchmark organization in cancer prevention with over three decades of profound experience. Its outstanding contributions have been praised by Dr. Margaret Chan Fung Fu-chun, former Director-General of the World Health Organization (WHO), and it has garnered long-term support from numerous public figures. Hong Kong Health Research Point is deeply committed to community health and grassroots care. This tripartite collaboration unites community trust with technological innovation.

(Trophies and letters of appreciation in the office of the Hong Kong Cancer Fund Angel Service Society, showcasing its deep-rooted legacy and public recognition.)

This powerful alliance quickly translated into tangible action. On April 29, the Hong Kong Cancer Fund Angel Service Society leveraged its extensive experience in public welfare services to provide screenings for the first group of women. The event was smooth and orderly. The Dr. Xiaoji robot won unanimous praise and trust from the participants for its accurate, efficient, and user-friendly experience.

(The Dr. Xiaoji robot providing precise screening services for women at the community event in Hong Kong on April 29.)

This community screening event is just the beginning. The three parties are now actively planning to expand the “Dr. Xiaoji” AI-powered community screening model across Hong Kong. Future plans include organizing more breast cancer screening activities targeting various at-risk groups at the grassroots level, extending the benefits of AI technology to even more women.